Sfoglia per AUTORE
MEZQUITA L
Collezione ASL Cuneo 2
Items : 2
1343P Adding histology-driven chemotherapy (ChT) to overcome primary resistance to first-line immunotherapy (ICI) in patients (pts) with advanced non-small cell lung cancer (aNSCLC) with PD-L1 ?50% in Annals of Oncology
2024
ASL Cuneo 2
ASL Cuneo 2
De Giglio A; Zullo L; Di Federico A; Cani M; Aldea M; Favorito V; Sadowska A; Hendriks LE; Gorría Puga T; Mezquita L; Tabbò F; Novello S; Ardizzoni A; Besse B; Gelsomino F;
1343P Adding histology-driven chemotherapy (ChT) to overcome primary resistance to first-line immunotherapy (ICI) in patients (pts) with advanced non-small cell lung cancer (aNSCLC) with PD-L1 ?50% in Annals of Oncology
2024
ASL Cuneo 2
ASL Cuneo 2
De Giglio A; Zullo L; Di Federico A; Cani M; Aldea M; Favorito V; Sadowska A; Hendriks LE; Gorría Puga T; Mezquita L; Tabbò F; Novello S; Ardizzoni A; Besse B; Gelsomino F;